全文获取类型
收费全文 | 2114篇 |
免费 | 259篇 |
国内免费 | 26篇 |
专业分类
耳鼻咽喉 | 3篇 |
儿科学 | 170篇 |
妇产科学 | 28篇 |
基础医学 | 211篇 |
口腔科学 | 71篇 |
临床医学 | 211篇 |
内科学 | 468篇 |
皮肤病学 | 40篇 |
神经病学 | 77篇 |
特种医学 | 356篇 |
外科学 | 213篇 |
综合类 | 135篇 |
预防医学 | 162篇 |
眼科学 | 21篇 |
药学 | 114篇 |
1篇 | |
中国医学 | 1篇 |
肿瘤学 | 117篇 |
出版年
2022年 | 9篇 |
2021年 | 25篇 |
2020年 | 13篇 |
2019年 | 25篇 |
2018年 | 44篇 |
2017年 | 26篇 |
2016年 | 28篇 |
2015年 | 44篇 |
2014年 | 44篇 |
2013年 | 71篇 |
2012年 | 48篇 |
2011年 | 35篇 |
2010年 | 54篇 |
2009年 | 98篇 |
2008年 | 50篇 |
2007年 | 79篇 |
2006年 | 68篇 |
2005年 | 53篇 |
2004年 | 57篇 |
2003年 | 57篇 |
2002年 | 62篇 |
2001年 | 60篇 |
2000年 | 86篇 |
1999年 | 52篇 |
1998年 | 109篇 |
1997年 | 123篇 |
1996年 | 119篇 |
1995年 | 88篇 |
1994年 | 88篇 |
1993年 | 107篇 |
1992年 | 43篇 |
1991年 | 36篇 |
1990年 | 32篇 |
1989年 | 55篇 |
1988年 | 50篇 |
1987年 | 31篇 |
1986年 | 46篇 |
1985年 | 38篇 |
1984年 | 23篇 |
1983年 | 22篇 |
1982年 | 23篇 |
1981年 | 37篇 |
1980年 | 22篇 |
1979年 | 13篇 |
1978年 | 10篇 |
1977年 | 22篇 |
1976年 | 22篇 |
1975年 | 8篇 |
1974年 | 6篇 |
1971年 | 5篇 |
排序方式: 共有2399条查询结果,搜索用时 15 毫秒
61.
62.
OBJECTIVES: To study the efficacy of otoacoustic emissions (OAEs) as a screening test for hearing impairment in children with acute bacterial meningitis. Hearing tests were performed before discharge from the hospital in an attempt to improve coverage and avoid delays in the diagnosis of postmeningitic hearing loss. METHODS: Children with bacterial meningitis were recruited from 21 centers. In the 48 hours before discharge from the hospital, all patients underwent a thorough audiologic assessment consisting of transient evoked OAEs, auditory brainstem responses (ABRs), otoscopy, and tympanometry. Hearing loss was defined as ABR threshold >/=30 dB. The results of OAE screening were compared with the gold standard of ABR threshold. RESULTS: Of 124 children recruited, we were able to perform both OAEs and ABRs on 110 children. Seven (6.3%) of the 110 children had ABR threshold >/=30 dB; 2 had sensorineural hearing loss and 5 had conductive hearing loss. At follow-up, hearing loss persisted in both cases of sensorineural hearing loss and no new cases were identified. All 7 children with hearing loss failed the OAE screening test. Ninety-four children with normal hearing thresholds passed the test, and 9 failed. Thus, the screening test had a sensitivity of 1.00 (95% confidence interval, 0.59 to 1.00), a specificity of 0.91 (0.85 to 0.97), a positive predictive value of 0. 44 (0.20 to 0.70), and a negative predictive value of 1.00 (0.96 to 1.00). CONCLUSIONS: OAE screening in children recovering from meningitis was found to be feasible and effective. The test was highly sensitive and reasonably specific. Inpatient OAE screening should allow early diagnosis of postmeningitic hearing loss and prompt auditory rehabilitation. 相似文献
63.
64.
65.
Cutaneous manifestations of malignancy are not uncommon, especially in advanced disease. They may also occur early in malignant disease or they may even signify recurrence particularly if they are paraneoplastic in nature. Clinical diagnosis can be difficult because of the wide spectrum of appearance of these lesions, and, in many cases, because of the lack of an identifiable underlying primary. Presented here is the case of a 65-year-old woman with multiple inflammatory cutaneous metastases, which were sclerodermoid in nature. These appeared 14 months after initial diagnosis of adenocarcinoma of unknown primary (ACUP) and signified the beginning of a rapid deterioration in her condition. The coexistence of limited systemic sclerosis (scleroderma) and ACUP initially raised several interesting diagnostic possibilities. Adenocarcinoma of unknown primary and the sclerodermoid reaction in malignancy are discussed. 相似文献
66.
67.
George A. Mensah Richard A. Goodman Stephanie Zaza Anthony D. Moulton Paula L. Kocher William H. Dietz Terry F. Pechacek James S. Marks 《Preventing chronic disease》2004,1(1)
Law, which is a fundamental element of effective public health policy and practice, played a crucial role in many of public health's greatest achievements of the 20th century. Still, conceptual legal frameworks for the systematic application of law to chronic disease prevention and control have not been fully recognized and used to address public health needs. Development and implementation of legal frameworks could broaden the range of effective public health strategies and provide valuable tools for the public health workforce, especially for state and local health department program managers and state and national policy makers. In an effort to expand the range of effective public health interventions, the Centers for Disease Control and Prevention will work with its partners to explore the development of systematic legal frameworks as a tool for preventing chronic diseases and addressing the growing epidemic of obesity, heart disease, stroke, and other chronic diseases and their risk factors. 相似文献
68.
69.
70.
Depressive symptoms in inflammatory bowel disease: an extraintestinal manifestation of inflammation?
C. D. Moulton P. Pavlidis C. Norton S. Norton C. Pariante B. Hayee N. Powell 《Clinical and experimental immunology》2019,197(3):308-318
Depressive symptoms are reported by more than 20% of people with inflammatory bowel disease (IBD), while sleep difficulties and fatigue are even more common. Co-morbid depressive symptoms predict a poor IBD course, including increased risk of relapse and surgery, which is inconsistently improved by psychological treatments. Rather than being distinct systems, there is compelling evidence for bidirectional communication between gut and brain, driven by neural, metabolic, endocrine and inflammatory mediators. An emerging concept is that depressive symptoms may be mechanistically linked to excess inflammation and dysregulation of the gut–brain axis. Given the close link between the intestinal microbiota and host immune responses, patients prone to shifts in their intestinal microbiome, including smokers, those with poor diet and early life stress, may be exposed to exaggerated immune responses. Excess inflammation is associated with brain changes (depressive symptoms, fatigue, sleep difficulties) and worsening gastrointestinal symptoms, which are exacerbated by psychological distress. Equally, treatments both for depressive symptoms and IBD provide opportunities to break this cycle by reducing the causes and effects of inflammation. As well as addressing potential risk factors such as smoking and diet, treatments to alter the microbiome may reduce depressive symptoms. Observational evidence suggests that anti-inflammatory treatments for IBD may improve co-morbid depressive symptoms correlating with reduction in inflammation. With a growing range of treatments targeting inflammation centrally, peripherally and in the gut, IBD provides a unique model to understand the interplay between brain and gut in the pathogenesis of depressive symptoms, both in IBD and in the whole population. 相似文献